Breaking News Instant updates and real-time market news.

2018-11-06 06:21:45 MYL Mylan $31.36 -0.31 (-0.98%) 06:21 11/06/18 11/06 06:21 11/06/18 06:21	Mylan says board hasn't put timeline on strategic alternatives Mylan said on Monday it had not set any timeline on evaluating its strategic alternatives. "I can assure you the board is busy looking at lots of things... But we put no timeframes around that," CEO Heather Bresch said on the company's Q3 earnings conference call. In August, Mylan's board formed a review committee to evaluate a "wide range" of alternatives.	13 Nov
MYL Mylan $31.36 -0.31 (-0.98%) 10/09/18 10/09/18 DOWNGRADE On The Fly: Top five analyst downgrades Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exelon (EXC) downgraded to Neutral from Overweight at JPMorgan and to Neutral from Buy at Citi. 2. CommScope (COMM) downgraded to Neutral from Buy at Goldman Sachs with analyst Mark Delaney saying he views the company's fundamental environment as "mixed" and views the stock's valuation as fair at current levels. 3. Mylan (MYL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying recent generics trends leave him seeing downside risk to consensus forecasts and Mylan's 2018 guidance. 4. Blackbaud (BLKB) downgraded to Market Perform from Outperform at Raymond James and JMP Securities as well as to Hold from Buy at Benchmark. 5. Kroger (KR) downgraded to Sell from Hold at Deutsche Bank while Smart & Final Stores (SFS) was downgraded to Hold from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. 10/12/18 WELS 10/12/18 NO CHANGE WELS Market Perform Merck returning Lantus biosimilar rights negative for Mylan, says Wells Fargo Wells Fargo analyst David Maris sees a negative read-through for Mylan regarding yesterday's news of Merck Sharp & Dohme Research returning the rights to biosimilar Lantus to Samsung Bioepis. While some view this as a positive, as there will likely be one fewer competitor in the market if Mylan-Biocon make it to the U.S. market, that is a "simplistic and optimistic" take, Maris tells investors in a research note. The more important factor to consider is the "why" Merck dropped out, rather than the number of competitors, the analyst writes. He believes Merck returned the rights to Samsung Bioepis due to the deteriorating pricing environment and pricing outlook for insulin and Lantus biosimilars. Lilly's and Sanofi's manufacturing capacity, along with aggressive discounting, has created a "severe pricing environment," Maris contends. He believes that if Samsung Bioepis and Merck can't make the economics work, than one should be skeptical of Mylan and Biocon having substantial success. Maris has a Market Perform rating on Mylan shares. 10/18/18 WELS 10/18/18 NO CHANGE WELS Sandoz results 'potential warning signal' for generics, says Wells Fargo Wells Fargo analyst David Maris views this morning's results from Novartis' (NVS) generic unit Sandoz as "another negative datapoint" for generic stocks, notably Teva (TEVA), Mylan (MYL) and Amneal Pharmaceuticals (AMNX). Novartis reported Sandoz net sales of $2.4B, down 4% on constant currency, and noted that sales were pressured by 8% pricing erosion in the quarter, Maris tells investors in a research note. Novartis also highlighted that U.S sales for Sandoz declined 17% due to "industry wide pricing pressure," Maris points out. The analyst views the quarter as a "potential warning signal" for the Q3 earnings season for companies with large U.S. commodity generic exposure. He maintains his caution on "generic industry margin risks." 11/01/18 WELS 11/01/18 NO CHANGE WELS Market Perform Fear of missing out helping to push Teva, Mylan higher, says Wells Fargo Wells Fargo analyst David Maris believes Teva (TEVA) shares are bouncing back to fair value from recent declines after the company reported Q3 earnings that beat his above consensus estimate and hosted a "surprisingly bullish" quarterly call. He also sees a spillover effect occurring with Mylan (MYL) as the generic sector's advance reinforces buyers' belief that the stocks are undervalued and investors' "fear of missing out" drives increased interest. While Maris acknowledges Ajovy, Austedo, cost cuts and tax management are doing well, he believes much of Teva's business continues to show significant challenges and keeps a Market Perform rating on the shares.

2018-11-06 06:21:45

MYL

Mylan

$31.36: -0.31 (-0.98%)

06:21

11/06/18

11/06

06:21

11/06/18

06:21

Mylan says board hasn't put timeline on strategic alternatives

Mylan said on Monday it had not set any timeline on evaluating its strategic alternatives. "I can assure you the board is busy looking at lots of things... But we put no timeframes around that," CEO Heather Bresch said on the company's Q3 earnings conference call. In August, Mylan's board formed a review committee to evaluate a "wide range" of alternatives.

13
Nov

MYL Mylan

$31.36: -0.31 (-0.98%)

10/09/18

10/12/18: WELS

10/18/18: WELS

11/01/18: WELS

TODAY'S FREE FLY STORIES

CXO Concho Resources $103.69 -8.68 (-7.72%) 18:37 02/21/19 02/21 18:37 02/21/19 18:37 Recommendations	Concho Resources analyst commentary » Concho Resources price… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 May 28 May
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 18:37 02/21/19 02/21 18:37 02/21/19 18:37 Hot Stocks	Kraft Heinz confirms quarterly dividend cut to 40c from 62.5c per share » The Board of Directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 18:32 02/21/19 02/21 18:32 02/21/19 18:32 Hot Stocks	Kraft Heinz says has taken 'remedial measures' on procurement issues » Says write down reflected… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
CZR Caesars $9.42 -0.21 (-2.18%) 18:25 02/21/19 02/21 18:25 02/21/19 18:25 Hot Stocks	Breaking Hot Stocks news story on Caesars » Caesars: Las Vegas FY19… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
RARE Ultragenyx $58.16 -2.33 (-3.85%) 18:20 02/21/19 02/21 18:20 02/21/19 18:20 Initiation	Ultragenyx initiated » Ultragenyx resumed with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

NSRGY Nestle $0.00 (0.00%) , CPB Campbell Soup $35.44 0.26 (0.74%) 18:13 02/21/19 02/21 18:13 02/21/19 18:13 Periodicals	Third Point says confident in Nestle CEO's leadership, Reuters reports » Third Point told… NSRGY Nestle $0.00 (0.00%) CPB Campbell Soup $35.44 0.26 (0.74%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 25 Feb 26 Feb 27 Feb 28 May
STMP Stamps.com $198.08 -4.03 (-1.99%) 18:11 02/21/19 02/21 18:11 02/21/19 18:11 Hot Stocks	Breaking Hot Stocks news story on Stamps.com » Stamps.com drops 50%… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 21 Feb
STMP Stamps.com $198.08 -4.03 (-1.99%) 18:09 02/21/19 02/21 18:09 02/21/19 18:09 Hot Stocks	Stamps.com to discontinue partnership with USPS » On its Q4 earnings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 21 Feb
CZR Caesars $9.42 -0.21 (-2.18%) 18:08 02/21/19 02/21 18:08 02/21/19 18:08 Hot Stocks	Caesars expect modest Las Vegas revenue growth in Q1 » Sees adverse weather… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
CZR Caesars $9.42 -0.21 (-2.18%) 18:06 02/21/19 02/21 18:06 02/21/19 18:06 Hot Stocks	Breaking Hot Stocks news story on Caesars » Caesars says will not… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

LNT Alliant Energy $45.63 0.45 (1.00%) 18:03 02/21/19 02/21 18:03 02/21/19 18:03 Earnings	Breaking Earnings news story on Alliant Energy » Alliant Energy sees FY19… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
LNT Alliant Energy $45.63 0.45 (1.00%) 18:02 02/21/19 02/21 18:02 02/21/19 18:02 Earnings	Alliant Energy reports Q4 EPS 36c, conseensus 35c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
BVN Buenaventura $16.53 -0.37 (-2.19%) 17:59 02/21/19 02/21 17:59 02/21/19 17:59 Earnings	Buenaventura reports Q4 EPS (29c), consensus 5c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Mar 12 Mar 12 Mar
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:58 02/21/19 02/21 17:58 02/21/19 17:58 Hot Stocks	Kraft Heinz says expects to face profit headwinds in 2019 » Says: Expects EBITDA down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
GABC German American Bancorp $31.59 (0.00%) , CZFC Citizens First $23.30 1.87 (8.73%) 17:56 02/21/19 02/21 17:56 02/21/19 17:56 Hot Stocks	German American, Citizens First announce merger pact » German American Bancorp,… GABC German American Bancorp $31.59 (0.00%) CZFC Citizens First $23.30 1.87 (8.73%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

TSLA Tesla $291.18 -11.33 (-3.75%) 17:56 02/21/19 02/21 17:56 02/21/19 17:56 Periodicals	Lucid Motors is 'working' on an all electric SUV, Verge says » Electric vehicle startup… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 18 Mar 19 Mar
CZR Caesars $9.42 -0.21 (-2.18%) 17:54 02/21/19 02/21 17:54 02/21/19 17:54 Hot Stocks	Caesars sees FY19 same-store capex $375M-$450M » Sees FY19 development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
PBA Pembina Pipeline $36.44 -0.235 (-0.64%) 17:54 02/21/19 02/21 17:54 02/21/19 17:54 Earnings	Pembina Pipeline reports Q4 EPS C$0.66 vs C$0.83 last year » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:53 02/21/19 02/21 17:53 02/21/19 17:53 Hot Stocks	Kraft Heinz continues to fall, now down 16.5% to $40.25 » In after-hours trading,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
CZR Caesars $9.42 -0.21 (-2.18%) 17:52 02/21/19 02/21 17:52 02/21/19 17:52 Hot Stocks	Caesars says in discussions with Carl Icahn after his disclosed stake » Comments from Q4 earnings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

HRS Harris $164.55 -0.62 (-0.38%) 17:48 02/21/19 02/21 17:48 02/21/19 17:48 Hot Stocks	Harris awarded $168.8M Navy contract modification » Harris has been awarded a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KHC Kraft Heinz $48.19 -0.05 (-0.10%) 17:45 02/21/19 02/21 17:45 02/21/19 17:45 Hot Stocks	Kraft Heinz to cut quarterly dividend to 40c from 62.5c per share » Says: Higher supply chain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
HON Honeywell $152.60 -1.2 (-0.78%) 17:43 02/21/19 02/21 17:43 02/21/19 17:43 Hot Stocks	Honeywell awarded not-to-exceed $150M Air Force contract for ATTAM Phase 1 » Honeywell has been… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Apr
BA Boeing $417.48 -4.13 (-0.98%) 17:40 02/21/19 02/21 17:40 02/21/19 17:40 Hot Stocks	Tapestry awarded not-to-exceed $259M Air Force contract for WPS » Tapestry Solutions, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Mar 28 May
INFN Infinera $4.87 -0.02 (-0.41%) 17:39 02/21/19 02/21 17:39 02/21/19 17:39 Earnings	Infinera sees Q1 EPS (27c) plus/minus 2c, consensus (19c) » Sees Q1 GAAP revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 26 Feb 27 Feb 28 Feb

Events

Earnings calls, analyst events, roadshows and more

IQ
Today at 19:00

iQIYI - IQ Conference Calls
BIDU
Today at 20:15

Baidu - BIDU Conference Calls
BBX
Tomorrow at 00:00

BBX Capital - BBX Conference Calls
Tomorrow at 00:00

Transplantation & Cellular Therapy Meetings of ASBMT & CIBMTR Conferences

Hilton Americas, Houston, TX
Tomorrow at 00:00

2019 Agricultural Outlook Forum Conferences

Crystal Gateway Marriott Hotel, Arlington, VA
NWL ...
Tomorrow at 00:00

CAGNY Conference 2019 Conferences

New York, NY
AIMT ...
Tomorrow at 00:00

AAAAI Annual Meeting 2019 Conferences

San Francisco, CA
Tomorrow at 00:00

IASLC 2019 Targeted Therapies of Lung Cancer Meeting Conferences

Fairmont Miramar Hotel, Santa Monica, CA
JPM ...
Tomorrow at 00:00

U.S. Monetary Policy Forum Conferences

InterContinental Barclay Hotel, New York, NY
Tomorrow at 00:00

Access Philippines Corporate Days Conferences

Singapore

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	ACAM X ACAM Acamar Partners IPO Managers: Goldman Sachs & Deutsche Bank Priced at: $10.00 30M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	TRIL X TRIL Trillium Therapeutics Spot Secondary Managers: Cowen $0.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Mylan says board hasn't put timeline on strategic alternatives

TODAY'S FREE FLY STORIES

Get Full Fly Access